These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
155 related items for PubMed ID: 7999772
41. The effect of the acidic tail on the DNA-binding properties of the HMG1,2 class of proteins: insights from tail switching and tail removal. Lee KB, Thomas JO. J Mol Biol; 2000 Nov 24; 304(2):135-49. PubMed ID: 11080451 [Abstract] [Full Text] [Related]
42. Thermodynamic properties of duplex DNA containing a site-specific d(GpG) intrastrand crosslink formed by an antitumor dinuclear platinum complex. Hofr C, Farrell N, Brabec V. Nucleic Acids Res; 2001 May 15; 29(10):2034-40. PubMed ID: 11353072 [Abstract] [Full Text] [Related]
43. DNA bending and unwinding due to the major 1,2-GG intrastrand cross-link formed by antitumor cis-diamminedichloroplatinum(II) are flanking-base independent. Stehlikova K, Kostrhunova H, Kasparkova J, Brabec V. Nucleic Acids Res; 2002 Jul 01; 30(13):2894-8. PubMed ID: 12087174 [Abstract] [Full Text] [Related]
44. Progesterone receptor-induced bending of its target DNA: distinct effects of the A and B receptor forms. Prendergast P, Pan Z, Edwards DP. Mol Endocrinol; 1996 Apr 01; 10(4):393-407. PubMed ID: 8721984 [Abstract] [Full Text] [Related]
45. Interaction of FACT, SSRP1, and the high mobility group (HMG) domain of SSRP1 with DNA damaged by the anticancer drug cisplatin. Yarnell AT, Oh S, Reinberg D, Lippard SJ. J Biol Chem; 2001 Jul 13; 276(28):25736-41. PubMed ID: 11344167 [Abstract] [Full Text] [Related]
46. DNA unwinding produced by site-specific intrastrand cross-links of the antitumor drug cis-diamminedichloroplatinum(II). Bellon SF, Coleman JH, Lippard SJ. Biochemistry; 1991 Aug 13; 30(32):8026-35. PubMed ID: 1868076 [Abstract] [Full Text] [Related]
48. Relationship of solution and protein-bound structures of DNA duplexes with the major intrastrand cross-link lesions formed on cisplatin binding to DNA. Marzilli LG, Saad JS, Kuklenyik Z, Keating KA, Xu Y. J Am Chem Soc; 2001 Mar 28; 123(12):2764-70. PubMed ID: 11456962 [Abstract] [Full Text] [Related]
51. Redox state-dependent interaction of HMGB1 and cisplatin-modified DNA. Park S, Lippard SJ. Biochemistry; 2011 Apr 05; 50(13):2567-74. PubMed ID: 21355578 [Abstract] [Full Text] [Related]
52. DNA binding and bending properties of the post-meiotically expressed Sry-related protein Sox-5. Connor F, Cary PD, Read CM, Preston NS, Driscoll PC, Denny P, Crane-Robinson C, Ashworth A. Nucleic Acids Res; 1994 Aug 25; 22(16):3339-46. PubMed ID: 8078769 [Abstract] [Full Text] [Related]
53. Characterization of a DNA damage-recognition protein from mammalian cells that binds specifically to intrastrand d(GpG) and d(ApG) DNA adducts of the anticancer drug cisplatin. Donahue BA, Augot M, Bellon SF, Treiber DK, Toney JH, Lippard SJ, Essigmann JM. Biochemistry; 1990 Jun 19; 29(24):5872-80. PubMed ID: 2383564 [Abstract] [Full Text] [Related]
54. HMG-D is an architecture-specific protein that preferentially binds to DNA containing the dinucleotide TG. Churchill ME, Jones DN, Glaser T, Hefner H, Searles MA, Travers AA. EMBO J; 1995 Mar 15; 14(6):1264-75. PubMed ID: 7720717 [Abstract] [Full Text] [Related]
55. High-mobility-group 1 protein mediates DNA bending as determined by ring closures. Pil PM, Chow CS, Lippard SJ. Proc Natl Acad Sci U S A; 1993 Oct 15; 90(20):9465-9. PubMed ID: 8415724 [Abstract] [Full Text] [Related]
56. The acidic tail of the high mobility group protein HMG-D modulates the structural selectivity of DNA binding. Payet D, Travers A. J Mol Biol; 1997 Feb 14; 266(1):66-75. PubMed ID: 9054971 [Abstract] [Full Text] [Related]
57. DNA bending by the chromosomal protein HMG1 and its high mobility group box domains. Effect of flanking sequences. Stros M. J Biol Chem; 1998 Apr 24; 273(17):10355-61. PubMed ID: 9553091 [Abstract] [Full Text] [Related]
58. Differential binding of HMG1, HMG2, and a single HMG box to cisplatin-damaged DNA. Farid RS, Bianchi ME, Falciola L, Engelsberg BN, Billings PC. Toxicol Appl Pharmacol; 1996 Dec 24; 141(2):532-9. PubMed ID: 8975778 [Abstract] [Full Text] [Related]
59. Single d(GpG)/cis-diammineplatinum(II) adduct-induced inhibition of DNA polymerization. Suo Z, Lippard SJ, Johnson KA. Biochemistry; 1999 Jan 12; 38(2):715-26. PubMed ID: 9888812 [Abstract] [Full Text] [Related]
60. Enhanced binding of the TATA-binding protein to TATA boxes containing flanking cisplatin 1,2-cross-links. Cohen SM, Jamieson ER, Lippard SJ. Biochemistry; 2000 Jul 18; 39(28):8259-65. PubMed ID: 10889034 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]